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Pyrizinostatin was obtained as colorless crystals, and its molecular formula was established as CnH15N5O4 by HRFAB-MS and elemental analysis. The IR spectrum exhibited strong absorption at 1680cm" 1 suggesting the presence of amide bond in the molecule (Fig. 2) . The UV spectra showed a maximumat 280nm (s 4,600) in MeOH. The 13C and XHNMRdata for pyrizinostatin are summarized in Table 1 . In the 13C NMRspectrum, the signals of 1 1 carbons were resolved and assigned to four methyl carbons, one methylene carbon, one quaternary carbon and five quaternary sp2 carbons by DEPTexperiment. In the *H NMRspectrum, characteristic signals due to four isolated methyl groups were observed, and the three methyl groups could be assigned to TV-methyl protons based on their 13C and *H chemical shifts. One exchangeable proton signal (S 5.75) was attributed to be NH proton because it gave positive color reaction with Greig-Leaback reagent2). All of the proton signals of pyrizinostatin was located, and then the proton-carbon correlations were obtained by a heteronuclear multiple-bond correlation (HMBC)3) experiment and assignment of *H and 13C NMR spectra were elucidated. The summaryof the 1H-13C long range coupling by HMBC measurements on pyrizinostatin is shown in Fig. 3 . The structure of pyrizinostratin was determined by crystal X-ray diffraction analysis. A colorless Fig. 1 . Structure of pyrizinostatin. Fig. 4 . Therefore, the structure of pyrizinostatin was determined to be 2,4,4a,8-tetrahydro-2,6,8-trimethyl-4a-(2-oxopropyl)-pyrimido [5,4- 
